DOI:
10.1055/s-00000140
Pädiatrie up2date
LinksClose Window
References
Brunner HI, Ruperto N, Tzaribachev N. et al.
Subcutaneous golimumab for children with active polyarticular-course juvenile idiopathic arthritis: results of a multicentre, double-blind, randomised-withdrawal trial.
Ann Rheum Dis 2018;
77: 21-29
We do not assume any responsibility for the contents of the web pages of other providers.